Pharmicell Co., Ltd.
Clinical trials sponsored by Pharmicell Co., Ltd., explained in plain language.
-
Stem cell therapy for ED after prostate surgery: safety check underway
Disease control Recruiting nowThis study follows 32 men who previously received an experimental stem cell treatment (Cellgram-ED) for erectile dysfunction after prostate removal. The goal is to monitor long-term safety, including tumor markers, serious side effects, and any cancer recurrence. Participants are…
Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Heart attack cell therapy under Long-Term safety watch
Disease control Recruiting nowThis study follows 100 people who had a heart attack and received the cell therapy Hearticellgram-AMI. Researchers are monitoring for serious side effects such as death, new cancers, or immune reactions over the long term. The goal is to ensure the treatment remains safe after it…
Phase: NA • Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:53 UTC